Gaetano Rocco, Giorgio Pennazza, Kay See Tan, Stijn Vanstraelen, Marco Santonico, Robert J Corba, Bernard J Park, Smita Sihag, Matthew J Bott, Pierfilippo Crucitti, James M Isbell, Michelle S Ginsberg, Hallie Weiss, Raffaele Antonelli Incalzi, Panaiotis Finamore, Filippo Longo, Alessandro Zompanti, Simone Grasso, Stephen B Solomon, Alain Vincent, Alexa McKnight, Michael Cirelli, Carmela Voli, Susan Kelly, Mario Merone, Daniela Molena, Katherine Gray, James Huang, Valerie W Rusch, Manjit S Bains, Robert J Downey, Prasad S Adusumilli, David R Jones
INTRODUCTION: Electronic nose (E-nose) technology has demonstrated excellent sensitivity and specificity in the setting of lung cancer screening. However, the performance of E-nose specifically for early-stage tumors remains unclear. Therefore, the aim of our study was to assess the diagnostic performance of E-nose technology in clinical stage I lung cancer. METHODS: This Phase-IIc trial (NCT04734145) included patients diagnosed with a single ≥50% solid stage I nodule...
May 16, 2024: Journal of Thoracic Oncology